BIOSYNTIA ApS: Financial statements 2019
CVR: 34892970
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 439,331 and a net result of DKK -8,227,909 compared with DKK -9,431,042 the year before. Equity in the 2019 report amounted to DKK 16,939,867. The solvency ratio was 89.3%. The company had 20 employees in the financial year.
- Gross Profit
- DKK 439,331
- Profit/Loss
- DKK -8,227,909
- Equity
- DKK 16,939,867
- Total Assets
- DKK 18,965,646
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 439 t. | -8.2 mio. | 16.9 mio. | 20 |
| 2018 | - | -2.7 mio. | -9.4 mio. | 25.2 mio. | 18 |
| 2017 | - | 2.2 mio. | -3.2 mio. | 4.8 mio. | 14 |
| 2016 | - | 619 t. | -2.8 mio. | 8 mio. | 8 |
| 2015 | - | 1.2 mio. | -1.7 mio. | 3.9 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of December 6, 2019, Thomas Grotkjær has joined the board of directors of BIOSYNTIA ApS.
As of December 6, 2019, Søren Møller has left the board of directors of BIOSYNTIA ApS.
BIOSYNTIA ApS has published its annual report for 2018. Gross profit came to DKK -2,671,636, and the net result was DKK -9,431,042.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees (2018). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.